Management of childhood epilepsy

CONTINUUM Lifelong Learning in Neurology

Volumn 19, Issue 3, 2013, Pages 656-681

  Glauser, Tracy A ^a   Loddenkemper, Tobias ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; CORTICOTROPIN; DIAZEPAM; ETHOSUXIMIDE; ETIRACETAM; FELBAMATE; GABAPENTIN; HARKOSERIDE; LAMOTRIGINE; LORAZEPAM; MESUXIMIDE; OXCARBAZEPINE; PERAMPANEL; PHENOBARBITAL; PHENYTOIN; PREGABALIN; PYRIDOXINE; RETIGABINE; RUFINAMIDE; STEROID; STIRIPENTOL; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ABSENCE; AGGRESSION; AGRANULOCYTOSIS; ALOPECIA; ANEMIA; ANHIDROSIS; ANOREXIA; ANTICONVULSANT THERAPY; APHASIA; APLASTIC ANEMIA; ASTHENIA; ATAXIA; ATTENTION DISTURBANCE; BALANCE DISORDER; BENIGN ROLANDIC EPILEPSY; BLOOD DYSCRASIA; BLURRED VISION; BRAIN DEPTH STIMULATION; BRAIN SURGERY; CARDIOMYOPATHY; CHILDHOOD ABSENCE EPILEPSY; CHRONOPHARMACOLOGY; CLINICAL DECISION MAKING; CLINICAL EVALUATION; CLINICAL FEATURE; CLINICAL SKIN REACTION; COGNITIVE DEFECT; COMBINATION CHEMOTHERAPY; CONFUSION; CONGESTIVE HEART FAILURE; CONSTIPATION; COORDINATION; COORDINATION DISORDER; CUSHINGOID SYNDROME; DEPRESSION; DIARRHEA; DIPLOPIA; DISEASE CLASSIFICATION; DIZZINESS; DROWSINESS; DRUG CHOICE; DRUG DEPENDENCE; DRUG DOSE TITRATION; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG WITHDRAWAL; DYSARTHRIA; DYSTONIA; EARLY DIAGNOSIS; ELECTROENCEPHALOGRAM; ELECTROLYTE DISTURBANCE; ERECTILE DYSFUNCTION; EXCITATION; FALLING; FATIGUE; FULMINANT HEPATIC NECROSIS; GASTROINTESTINAL SYMPTOM; GENERALIZED EPILEPSY; GINGIVA HYPERPLASIA; GLUCOSURIA; HEMISPHERECTOMY; HEPATITIS; HICCUP; HIRSUTISM; HUMAN; HYPERAMMONEMIA; HYPERGLYCEMIA; HYPERKINESIA; HYPERSALIVATION; HYPERTENSION; HYPONATREMIA; IMMUNOSUPPRESSIVE TREATMENT; IMPOTENCE; INFANTILE SPASM; INFECTION; INSOMNIA; IRRITABILITY; KETOGENIC DIET; LANDAU KLEFFNER SYNDROME; LENNOX GASTAUT SYNDROME; LETHARGY; LEUKOPENIA; LIVER FAILURE; LIVER NECROSIS; LIVER TOXICITY; MEDICATION COMPLIANCE; MEMORY DISORDER; MENTAL INSTABILITY; METABOLIC ACIDOSIS; MONOTHERAPY; MOTOR DYSFUNCTION; MUSCLE HYPOTONIA; MYOCLONUS EPILEPSY; NAUSEA; NAUSEA AND VOMITING; NEPHROLITHIASIS; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; NYSTAGMUS; OHTAHARA SYNDROME; OVARY POLYCYSTIC DISEASE; PANAYIOTOPOULOS SYNDROME; PANCREATITIS; PARESTHESIA; PATIENT MONITORING; PEDIATRIC SURGERY; POLLAKISURIA; PORPHYRIA CUTANEA TARDA; POSITRON EMISSION TOMOGRAPHY; PR INTERVAL; QT INTERVAL; QT PROLONGATION; RESPIRATION DEPRESSION; RESTLESSNESS; REVIEW; ROLANDIC EPILEPSY; SEDATION; SEVERE MYOCLONIC EPILEPSY IN INFANCY; SIDE EFFECT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SKIN BRUISING; SLURRED SPEECH; SOMNOLENCE; STEVENS JOHNSON SYNDROME; TREATMENT RESPONSE; TREATMENT WITHDRAWAL; TREMOR; UNSPECIFIED SIDE EFFECT; UNSTEADY GAIT; URINE RETENTION; VAGUS NERVE STIMULATION; VERTIGO; VISUAL FIELD DEFECT; VOMITING; WEIGHT GAIN; WEIGHT REDUCTION; WEST SYNDROME; XEROSTOMIA;

ALGORITHMS; ANTICONVULSANTS; CHILD; DECISION SUPPORT TECHNIQUES; EPILEPSY; FEMALE; HUMANS; NEUROSURGICAL PROCEDURES;

EID: 84880166779     PISSN: 10802371     EISSN: 15386899     Source Type: Journal    
DOI: 10.1212/01.CON.0000431381.29308.85     Document Type: Review

References (41)

1. Loddenkemper T, Wyllie E. Diagnostic issues in children. In: Schachter SC, LaFrance Jr, WC, eds. Gates and Rowan's nonepileptic seizures. 3rd edition. New York: Cambridge University Press, 2010:91-109.
2. Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 2010;51(4):676-685.
3. Musicco M, Beghi E, Solari A, Viani F. Treatment of first tonic clonic seizure does not improve the prognosis of epilepsy. First Seizure Trial Group (FIRST Group). Neurology 1997;49(4):991-998. (Pubitemid 27456076)
4. Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies [erratum published in Epilepsia 2010;51(9):1922]. Epilepsia 2010;51(6): 1069-1077.
5. Pestian J, Matykiewicz P, Holland-Bouley K, et al. Selecting anti-epileptic drugs: a pediatric epileptologist's view, a computer's view [published online ahead of print]. Acta Neurol Scand 2012. doi:10.1111/ane. 12002.
6. Glauser TA, Cnaan A, Shinnar S, et al. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy. N Engl J Med 2010;362(9):790-799.
7. Pellock JM, Carman WJ, Thyagarajan V, et al. Efficacy of antiepileptic drugs in adults predicts efficacy in children: a systematic review. Neurology 2012;79(14):1482-1489.
8. Bourgeois BF, Goodkin HP. Efficacy of antiepileptic drugs in adults vs children: does one size fit all? Neurology 2012;79(14): 1420-1421.
9. Morita DA, Glauser TA, Modi AC: Development and validation of the Pediatric Epilepsy Side Effects Questionnaire. Neurology 2012;79(12):1252-1258.
10. Glauser TA. Biomarkers for antiepileptic drug response. Biomark Med 2011;5(5):635-641.
11. Lockman J, Fisher RS, Olson DM. Detection of seizure-like movements using a wrist accelerometer. Epilepsy Behav 2011;20(4): 638-641.
12. Poh MZ, Loddenkemper T, Reinsberger C, et al. Convulsive seizure detection using a wrist-worn electrodermal activity and accelerometry biosensor. Epilepsia 2012; 53(5):e93-e97.
13. Dudley RW, Penney SJ, Buckley DJ. First-drug treatment failures in children with newly diagnosed epilepsy. Pediatr Neurol 2009; 40(2):71-77.
14. Arhan E, Serdaroglu A, Kurt AN, Aslanyavrusu M: Drug treatment failures and effectivity in children with newly diagnosed epilepsy. Seizure 2010;19(9): 553-557.
15. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000; 342(5):314-319. (Pubitemid 30075244)
16. Loddenkemper T, Lockley SW, Kaleyias J, Kothare SV: Chronobiology of epilepsy: diagnostic and therapeutic implications of chrono-epileptology. J Clin Neurophysiol 2011;28(2):146-153.
17. Guilhoto LM, Loddenkemper T, Vendrame M, et al. Higher evening antiepileptic drug dose for nocturnal and early-morning seizures. Epilepsy Behav 2011;20(2): 334-347.
18. Desai J, Mitchell WG. Does one more medication help? Effect of adding another anticonvulsant in childhood epilepsy. J Child Neurol 2011;26(3):329-333.
19. Modi AC, Rausch JR, Glauser TR. Patterns of nonadherence to antiepileptic drug therapy in children with newly diagnosed epilepsy. JAMA 2011;305(16):1669-1679.
20. Modi AC, Ingerski LM, Rausch JR, et al. White coat adherence over the first year of therapy in pediatric epilepsy. J Pediatr 2012;161(4):695-699.e1.
21. Modi AC, Guilfoyle SM, Morita DA, Glauser TA. Development and reliability of a correction factor for parent reported adherence to pediatric antiepileptic drug therapy. Epilepsia 2011;52(2):370-376.
22. Jette N, Quan H, Tellez-Zenteno JF, et al. Development of an online tool to determine appropriateness for an epilepsy surgery evaluation. Neurology 2012; 79(11):1084-1093.
23. Vendrame M, Loddenkemper T. Approach to seizures, epilepsies, and epilepsy syndromes. Sleep Med Clin 2012:7(1):59-73.
24. Wyllie E, Comair YG, Kotagal P, et al. Seizure outcome after epilepsy surgery in children and adolescents. Ann Neurol 1998:44(5): 740-748. (Pubitemid 28516044)
25. Krsek P, Maton B, Jayakar P, et al. Incomplete resection of focal cortical dysplasia is the main predictor of poor postsurgical outcome. Neurology 2009;72(3):217-223.
26. Souza-Oliveira C, Escorsi-Rosset S, Terra VC, et al. Impact of pediatric epilepsy surgery on intellectual efficiency. Rev Neurol 2012; 54(4):214-220.
27. Widjaja E, Li B, Schinkel CD, et al. Cost-effectiveness of pediatric epilepsy surgery compared to medical treatment in children with intractable epilepsy. Epilepsy Res 2011;94(1-2):61-68.
28. Valencia I, Holder DL, Helmers SL, et al. Vagus nerve stimulation in pediatric epilepsy: a review. Pediatr Neurol 2001;25(5):368-376. (Pubitemid 34015993)
29. Englot DJ, Chang EF, Auguste KI. Efficacy of vagus nerve stimulation for epilepsy by patient age, epilepsy duration, and seizure type. Neurosurg Clin N Am 2011;22(4):443-448, v.
30. Klinkenberg S, van den Bosch CN, Majoie HJ, et al. Behavioural and cognitive effects during vagus nerve stimulation in children with intractable epilepsyVa randomized controlled trial. Eur J Paediatr Neurol 2013;17(1):82-90.
31. Kossoff EH. Intractable childhood epilepsy: choosing between the treatments. Semin Pediatr Neurol 2011;18(3):145-149.
32. Kossoff EH, Zupec-Kania BA, Amark PE, et al Charlie Foundation, Practice Committee of the Child Neurology Society; Practice Committee of the Child Neurology Society; International Ketogenic Diet Study Group. Optimal clinical management of children receiving the ketogenic diet: recommendations of the International Ketogenic Diet Study Group. Epilepsia 2009;50(2):304-317.
33. Kossoff EH, Hartman AL. Ketogenic diets: new advances for metabolism-based therapies. Curr Opin Neurol 2012;25(2):173-178.
34. Vezzani A, French J, Bartfai T, Baram TZ. The role of inflammation in epilepsy. Nat Rev Neurol 2011;7(1):31-40.
35. Arya R, Shinnar S, Glauser TA. Corticosteroids for the treatment of infantile spasms: a systematic review. J Child Neurol 2012;27(10): 1284-1288.
36. Vieker S, Schmitt J, Langler A, Schmidt W, Klepper J. Unusual sensitivity to steroid treatment in intractable childhood epilepsy suggests GLUT1 deficiency syndrome. Neuropediatrics 2012;43(5):275-278.
37. Armangue T, Petit-Pedrol M, Dalmau J. Autoimmune encephalitis in children. J Child Neurol 2012;27(11):1460-1469.
38. Bok LA, Halbersma FJ, Houlterman S, et al. Long-term outcome in pyridoxine-dependent epilepsy. Dev Med Child Neurol 2012;54(9): 849-854.
39. Stockler S, Plecko B, Gospe SM Jr, et al. Pyridoxine dependent epilepsy and antiquitin deficiency: clinical and molecular characteristics and recommendations for diagnosis, treatment and follow up. Mol Genet Metab 2011;104(1-2):48-60.
40. Pestian J, Spencer M, Matykiewicz P, et al. Personalizing drug selection using advanced clinical decision support. Biomed Inform Insights 2009;2:19-29.
41. Fisher RS. Therapeutic devices for epilepsy. Ann Neurol 2012;71(2):157-168.